Skip to main navigation Skip to search Skip to main content

SUAVE trial: a randomised phase II study of sunitinib versus dacarbazine in the treatment of patients with metastatic uveal melanoma.

  • E Marshall
  • , S Coupland
  • , P Corrie
  • , B Damato
  • , S Danson
  • , L Dobson
  • , J Evans
  • , A Goodman
  • , H Kalirai
  • , S Jones
  • , S Kumar
  • , J Larkin
  • , P Lorigan
  • , S Nicholson
  • , C Ottensmeier
  • , P Silcocks
  • , N Steven
  • , C Tudur-Smith
  • , P. Nathan

    Research output: Chapter in Book/Conference proceeding › Conference contribution

    Original languageEnglish
    Title of host publicationhost publication
    Publication statusPublished - Jun 2012
    EventASCO Annual Meeting 2012 - McCormick Place, Chicago USA
    Duration: 1 Jun 2012 → 5 Jun 2012

    Conference

    ConferenceASCO Annual Meeting 2012
    CityMcCormick Place, Chicago USA
    Period1/06/12 → 5/06/12

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this